WB-EMS and Nutrition in Patients With Hematological Malignancies
Hematologic Diseases, Cachexia; Cancer, Leukemia
About this trial
This is an interventional supportive care trial for Hematologic Diseases focused on measuring hematological malignancies, leukemia, myeloma, lymphoma, exercise, nutrition, protein, WB-EMS, whole-body electromyostimulation
Eligibility Criteria
Inclusion Criteria:
- adult patients diagnosed with hematological malignancies with an indication for stem cell Transplantation
- Interval until Transplantation: 6 weeks
- ECOG Status 0-2
Exclusion Criteria:
- patients with serious osteolytic lesions and increased risk of fall
- simultaneous participation in other nutritional or exercise intervention Trials or in the past 6 months
- acute cardiovascular events
- use of anabolic medications
- epilepsy
- severe neurological diseases
- skin lesions in the area of electrodes
- energy active metals in body
- acute vein thrombosis
- rheumatic diseases
- pregnant and nursing women
- psychiatric disorders with doubts about legal and cognitive capacity
Sites / Locations
- Department of Medicine 1, Hector Center for Nutrition, Exercise and Sports, Friedrich-Alexander-University Erlangen-NurembergRecruiting
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
Control group
WB-EMS group
usual care" control group receives individualized nutritional support (dietary advices: daily protein intake 1.2-1.5 g/kg bodyweight), active exercise therapy is optionally provided (bicycle ergometers at room) during the in-Patient stay
physical exercise group regular WB-EMS training (2 EMS trainings per week; each session for 20 min) + individualized nutritional support (dietary advices: daily protein intake 1.2-1.5 g/kg bodyweight) active exercise therapy is optionally provided (bicycle ergometers at room) during the in-Patient stay